IMC, another TMA lyase inhibitor, reduced TMAO and BNP levels in HF mice, downregulated profibrotic gene expression, and mitigated TMAO-induced cardiac remodeling and dysfunction. This evidence concerns the gene NPPB and hydrops fetalis.